Floatz logo

ds-5565

Mirogabalin

Pusan National University Yangsan HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Mirogabalin cohort.

Asset / SponsorPhaseRating
Duloxetine
Pusan National University Yangsan Hospital
N/AD

Same molecule, other indications

ds-5565 is also rated in:

diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
Central Neuropathic PainDormant
BB
Indicative ·
64 / 100
View asset →
postherpetic neuralgiaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →